 Biomerica NASDAQ: BMRA is one of 27 public companies in the Diagnostic substances industry, but how does it compare to its rivals? We will compare Biomerica to similar businesses based on the strength of its analyst recommendations, risk, dividends, institutional ownership, profitability, valuation and earnings. Volatility and Risk Biomerica has a beta of -0.9, indicating ... 